The award will go towards the development of CTX-002 in preparation for clinical studies.
Startup Ancerix to commercialize much needed tool kit for surgeons
Data shared via a poster presentation at the recent American Foregut Society (AFS) Annual MeetingContinue reading
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement after the U.S. Food and Drug Administration (FDA) released a proposed rule that would seek to regulate Laboratory Developed Tests (LDTs) as medical devices under the Federal Food, Drug, and Cosmetic Act. ACLA does not believe that FDA’s actions are in the best interest of patients or our nation’s health care system. Because the proposed rule exceeds FDA’s existing authority, ACLA plans to submit comments urging FDA to withdraw the proposed rule and resume work with Congress, the laboratory community, patient groups, and other stakeholders toward a legislative solution that provides a framework that is appropriate for the unique attributes of LDTs.Continue reading
For Immediate Release:
September 29, 2023
Today, the U.S. Food and Drug Administration announced a proposed rule regarding laboratory developed tests, or LDTs, which play an important role in healthcare. The rule is aimed at helping to ensure the safety and effectiveness of these tests, which are used in a growing number of health care decisions and for which concerns have been raised for many years.Continue reading
Arizona will see its first medical school in Flagstaff as part of the Arizona Board of Regents’ call to its public universities to close the health care workforce gap in the state.Continue reading
AZBio Board Member Dr. Steve Potts discusses the negative impacts provisions of the Inflation Reduction Act (IRA) are having on the health innovation pipeline with Duane Schulthess, Managing Director of Vital Transformation, on the Vital Health Podcast.Continue reading
Using click-release proteolysis targeting chimeras, researchers have developed a new method of activating specific molecules to target cancer cells without harming healthy cells.Continue reading
PHOENIX (Sept. 26, 2023) – Newsweek has again named Barrow Neurological Institute one of the World’s Best Specialized Hospitals for Neurosurgery.
In its third year of ranking hospitals in neurosurgery, the media company continues to recognize Barrow as No. 1 in the Southwest and No. 10 in the nation. The Institute climbed two spots globally, sitting at No. 13 for 2024. The list includes 125 hospitals total.Continue reading